Source: Medical Device News Magazine

RenalGuard: RenalGuard Therapy Clinical Trial Results Published in the European Journal of Cardio-Thoracic Surgery

December 7, 2020 RenalGuard Therapy better protects at-risk patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) from Acute Kidney Injury (AKI) according to the KIDNEY clinical trial reports RenalGuard Solutions, a pioneering medical device company focused on protecting patients from AK. Results of the 220 patient, randomized trial comparing automated diuresis technology to standard hydration [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jim Dillon's photo - CEO of RenalGuard

CEO

Jim Dillon

CEO Approval Rating

84/100

Read more